Skip directly to searchSkip directly to the site navigationSkip directly to the page's main content

Incidence of Acute Myeloid Leukemia

Summary Indicator Report Data View Options

Incidence of Acute Myeloid Leukemia by County, Males, 2016-2020

Incidence of Acute Myeloid Leukemia by County, Females, 2016-2020

Why Is This Important?

During 2020, 249 New Jersey males and 223 females of all ages were diagnosed with acute myeloid leukemia. At this time, we do not know what causes most leukemias.

Definition

Incidence rate of leukemia by sub-type for a defined population in a specified time interval. Rates are age-adjusted to the 2000 U.S. Standard Population. Rates are per 100,000 population.

Data Sources

How the Measure is Calculated

Numerator:Number of new cases of leukemia by sub-type among a defined population in a specified time interval.
Denominator:Defined population in a specified time interval.

How Are We Doing?

The four most common types of leukemias occur with differing frequencies in adults versus children. Acute lymphocytic leukemia (ALL) is the most common type of childhood leukemia and also affects adults, especially those age 65 and older. Acute myeloid leukemia (AML) occurs in both adults and children. Chronic lymphocytic leukemia most commonly affects adults over age 55, and rarely occurs in children. Chronic myeloid leukemia (CML) occurs mainly in adults. Leukemia incidence rates and counts by age group are provided for the four most common types of leukemia. Detailed incidence rates and counts by gender and county are provided for the two most common types of leukemia (AML and CLL). Although it is often thought of as a children's disease, most cases of leukemia occur in older adults. Leukemia is ten times more common in adults than in children, and more than half of all leukemia cases occur in people over the age of 65.

What Is Being Done?

A Comprehensive Cancer Control Plan was developed by the Task Force on Cancer Prevention, Early Detection and Treatment in New Jersey which aims to reduce the incidence, illness and death due to cancer among New Jersey residents. [https://www.nj.gov/health/ces/documents/NJ%20Comprehensive%20Cancer%20Control%20Plan.pdf]

Available Services

The New Jersey Department of Health (NJDOH) has many programs and partnerships related to cancer data and information, cancer resources and cancer prevention. Cancer Epidemiology Services: [https://nj.gov/health/ces/] Interactive New Jersey cancer incidence and mortality data, as well as numerous publications, are available through the NJDOH website for cancer statistics and mapping. [https://www.nj.gov/health/ces/cancer-researchers/cancer-data/index.shtml] Office of Cancer Control and Prevention: [https://www.nj.gov/health/ces/public/resources/occp.shtml] NJ Cancer Education and Early Detection (NJCEED): [https://www.nj.gov/health/ces/public/resources/njceed.shtml] NJ Commission on Cancer Research: [https://www.nj.gov/health/ces/cancer-researchers/njccr.shtml]

Indicator Data Last Updated On 10/24/2023, Published on 05/24/2024
Cancer Epidemiology Services, New Jersey Department of Health, PO Box 369, Trenton, NJ 08625-0369, e-mail: cancer@doh.nj.gov (https://www.nj.gov/health/ces)